Background Epstein-Barr virus (EBV) is a known risk factor for multiple sclerosis (MS), even though the underlying molecular mechanisms are unclear and engage multiple immune pathways. Furthermore, the ultimate role of EBV in MS pathogenesis is still elusive. In contrast, Cytomegalovirus (CMV) has been identified as a protective factor for MS. Objectives This study aims to identify MS-associated genes that overlap with EBV interactome and to examine their expression in immune and glial cell subtypes. Methods We used P-HIPSTer, GWAS, and the Human Protein Atlas (HPA) to derive data on the EBV interactome, MS-associated genes and single-cell gene expression in immune and glial cells. The geneOverlap and dplyr R packages identified overlapping genes. A similar analysis was done for CMV and Adenovirus as negative control. Metascape and GTEx analyzed biological pathways and brain-level gene expression; transcriptomic analysis was performed on glial cells and peripheral blood in MS and controls. All the analyses performed in this study were generated using publicly available data sets. Results We identified a "core" group of 21 genes shared across EBV interactome, MS genes, and immune and glial cells (p<0.001). Pathway analysis revealed expected associations, such as immune system activation, and unforeseen results, like the prolactin signaling pathway. BCL2 in astrocytes, MINK1 in microglia were significantly upregulated while AHI1 was downregulated in MS compared to controls. Conclusions Our findings offer novel insights into EBV and CMV interaction with immune and glial cells in MS, that may shed light on mechanisms involved in disease pathophysiology.

Exploring the role of EBV in multiple sclerosis pathogenesis through EBV interactome / Ballerini, C.; Amoriello, R.; Maghrebi, O.; Bellucci, G.; Addazio, I.; Betti, M.; Aprea, M. G.; Masciulli, C.; Caporali, A.; Penati, V.; Ballerini, C.; De Meo, E.; Portaccio, E.; Salvetti, M.; Amato, M. P.. - In: FRONTIERS IN IMMUNOLOGY. - ISSN 1664-3224. - 16:(2025). [10.3389/fimmu.2025.1557483]

Exploring the role of EBV in multiple sclerosis pathogenesis through EBV interactome

Ballerini C.;Bellucci G.;Caporali A.;Salvetti M.;
2025

Abstract

Background Epstein-Barr virus (EBV) is a known risk factor for multiple sclerosis (MS), even though the underlying molecular mechanisms are unclear and engage multiple immune pathways. Furthermore, the ultimate role of EBV in MS pathogenesis is still elusive. In contrast, Cytomegalovirus (CMV) has been identified as a protective factor for MS. Objectives This study aims to identify MS-associated genes that overlap with EBV interactome and to examine their expression in immune and glial cell subtypes. Methods We used P-HIPSTer, GWAS, and the Human Protein Atlas (HPA) to derive data on the EBV interactome, MS-associated genes and single-cell gene expression in immune and glial cells. The geneOverlap and dplyr R packages identified overlapping genes. A similar analysis was done for CMV and Adenovirus as negative control. Metascape and GTEx analyzed biological pathways and brain-level gene expression; transcriptomic analysis was performed on glial cells and peripheral blood in MS and controls. All the analyses performed in this study were generated using publicly available data sets. Results We identified a "core" group of 21 genes shared across EBV interactome, MS genes, and immune and glial cells (p<0.001). Pathway analysis revealed expected associations, such as immune system activation, and unforeseen results, like the prolactin signaling pathway. BCL2 in astrocytes, MINK1 in microglia were significantly upregulated while AHI1 was downregulated in MS compared to controls. Conclusions Our findings offer novel insights into EBV and CMV interaction with immune and glial cells in MS, that may shed light on mechanisms involved in disease pathophysiology.
2025
CMV; EBV; MS pathogenesis; immune cells; interactome
01 Pubblicazione su rivista::01a Articolo in rivista
Exploring the role of EBV in multiple sclerosis pathogenesis through EBV interactome / Ballerini, C.; Amoriello, R.; Maghrebi, O.; Bellucci, G.; Addazio, I.; Betti, M.; Aprea, M. G.; Masciulli, C.; Caporali, A.; Penati, V.; Ballerini, C.; De Meo, E.; Portaccio, E.; Salvetti, M.; Amato, M. P.. - In: FRONTIERS IN IMMUNOLOGY. - ISSN 1664-3224. - 16:(2025). [10.3389/fimmu.2025.1557483]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1764687
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact